SEER - Seer, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Redwood City,
United States
Type: Equity
SEER price evolution
SEER
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $32.47 | $54.92 | $33.02 | |
| Short term investments | $251.51 | $254.15 | $283.73 | |
| Net receivables | $6.45 | $5.7 | $6.15 | $6.72 |
| Inventory | $6.93 | $7.58 | $5.81 | $4.49 |
| Total current assets | $264.1 | $299.69 | $324.15 | $330.51 |
| Long term investments | $61.19 | $50.64 | $56.86 | |
| Property, plant & equipment | $44.02 | $44.39 | $45.75 | $47.37 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $106.92 | $97.81 | $105.76 | |
| Total investments | $312.69 | $304.79 | $340.58 | |
| Total assets | $383.42 | $406.61 | $421.96 | $436.27 |
| Current liabilities | ||||
| Accounts payable | $0.74 | $4.63 | $2.56 | $1.37 |
| Deferred revenue | $0.19 | $0.27 | $0.21 | |
| Short long term debt | $2.27 | $2.28 | $2.29 | |
| Total current liabilities | $14.38 | $17.04 | $12.83 | $13.22 |
| Long term debt | $24.83 | $25.4 | $25.96 | |
| Total noncurrent liabilities | $24.88 | $25.58 | $26.14 | |
| Total debt | $27.1 | $27.68 | $28.26 | |
| Total liabilities | $38.7 | $41.91 | $38.41 | $39.37 |
| Shareholders' equity | ||||
| Retained earnings | -$370.63 | -$349.3 | -$326.45 | -$305.77 |
| Other shareholder equity | $0.79 | -$0.63 | -$0.52 | -$0.19 |
| Total shareholder equity | $364.7 | $383.56 | $396.9 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.02 | $53.73 | $233.34 | $333.93 |
| Short term investments | $283.73 | $368.03 | $167.26 | $98.28 |
| Net receivables | $6.72 | $7.02 | $4.14 | $0.26 |
| Inventory | $4.49 | $4.63 | $4.14 | $0.55 |
| Total current assets | $330.51 | $434.98 | $411.7 | $433.13 |
| Long term investments | $56.86 | $5.16 | $93.19 | |
| Property, plant & equipment | $47.37 | $46.41 | $33.23 | $8.44 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $105.76 | $52.95 | $127.44 | $9.19 |
| Total investments | $340.58 | $373.19 | $260.45 | $98.28 |
| Total assets | $436.27 | $487.93 | $539.14 | $442.32 |
| Current liabilities | ||||
| Accounts payable | $1.37 | $2.1 | $3.79 | $2.12 |
| Deferred revenue | $0.21 | $0.13 | $0.38 | $0.25 |
| Short long term debt | $2.29 | $1.84 | $0.86 | |
| Total current liabilities | $13.22 | $12.58 | $13.42 | $8.09 |
| Long term debt | $25.96 | $28.03 | $22.46 | |
| Total noncurrent liabilities | $26.14 | $28.35 | $22.8 | $2.62 |
| Total debt | $28.26 | $29.87 | $23.32 | |
| Total liabilities | $39.37 | $40.94 | $36.22 | $10.71 |
| Shareholders' equity | ||||
| Retained earnings | -$305.77 | -$219.5 | -$126.53 | -$55.36 |
| Other shareholder equity | -$0.19 | -$1.25 | -$0.54 | $0.05 |
| Total shareholder equity | $396.9 | $446.99 | $502.92 | $431.61 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4.03 | $3.07 | $3.07 | $4.44 |
| Cost of revenue | $1.34 | $1.71 | $2.44 | |
| Gross Profit | $1.94 | $1.73 | $1.36 | $2 |
| Operating activities | ||||
| Research & development | $12.73 | $12.27 | $11.16 | |
| Selling, general & administrative | $16.09 | $14.29 | $13.07 | |
| Total operating expenses | $26.26 | $28.83 | $26.55 | $24.23 |
| Operating income | -$27.1 | -$25.19 | -$22.23 | |
| Income from continuing operations | ||||
| EBIT | -$22.85 | -$20.68 | -$17.8 | |
| Income tax expense | ||||
| Interest expense | $3.22 | |||
| Net income | ||||
| Net income | -$21.33 | -$22.85 | -$20.68 | -$17.8 |
| Income (for common shares) | -$22.85 | -$20.68 | -$17.8 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $16.66 | $15.49 | $6.62 | $0.66 |
| Cost of revenue | $8.15 | $8.4 | $3.21 | |
| Gross Profit | $8.51 | $7.09 | $3.41 | $0.66 |
| Operating activities | ||||
| Research & development | $53.02 | $45.8 | $29.12 | $18.94 |
| Selling, general & administrative | $58.95 | $58.53 | $45.76 | $15.36 |
| Total operating expenses | $111.97 | $104.33 | $74.89 | $34.3 |
| Operating income | -$103.46 | -$97.23 | -$71.47 | -$33.65 |
| Income from continuing operations | ||||
| EBIT | -$86.28 | -$92.97 | -$71.15 | -$32.77 |
| Income tax expense | ||||
| Interest expense | $0.02 | |||
| Net income | ||||
| Net income | -$86.28 | -$92.97 | -$71.17 | -$32.77 |
| Income (for common shares) | -$86.28 | -$92.97 | -$71.17 | -$32.77 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$22.85 | -$20.68 | -$17.8 | |
| Operating activities | ||||
| Depreciation | $1.53 | $1.52 | $1.63 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.67 | $7.58 | $7.61 | |
| Total cash flows from operations | -$10.07 | -$10.46 | -$10.19 | |
| Investing activities | ||||
| Capital expenditures | -$1.17 | -$0.75 | -$1.84 | |
| Investments | -$7.61 | $33.11 | $7.95 | |
| Total cash flows from investing | $50.01 | -$8.78 | $32.35 | $6.11 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$3.6 | $0.18 | ||
| Net borrowings | ||||
| Total cash flows from financing | -$10.24 | -$3.6 | $0.18 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $5.12 | -$22.45 | $21.9 | -$3.9 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$86.28 | -$92.97 | -$71.17 | -$32.77 |
| Operating activities | ||||
| Depreciation | $5.79 | $5.9 | $3.56 | $1.61 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $34.42 | $33.67 | $25.93 | $7.35 |
| Total cash flows from operations | -$59.06 | -$60.78 | -$46.35 | -$20.83 |
| Investing activities | ||||
| Capital expenditures | -$7.31 | -$10.1 | -$6.92 | -$4.53 |
| Investments | $45.21 | -$112.62 | -$163.96 | -$30.02 |
| Total cash flows from investing | $37.9 | -$122.72 | -$170.88 | -$34.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.45 | $3.89 | $105.23 | $316.59 |
| Net borrowings | ||||
| Total cash flows from financing | $0.45 | $3.89 | $116.63 | $371.49 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$20.71 | -$179.6 | -$100.59 | $316.1 |
News
Fundamentals
| Market cap | $137.64M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 59.58M |
| Revenue | $14.61M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$82.66M |
| Revenue Q/Q | -3.12% |
| Revenue Y/Y | -13.19% |
| P/E ratio | -1.67 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 9.42 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$1.39 |
|---|---|
| ROA | -20.06% |
| ROE | N/A |
| Debt/Equity | 0.10 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 18.36 |
| Quick ratio | 17.88 |